27 found
Order:
Disambiguations
Bridget Haire [20]Bridget G. Haire [5]Bridget Gabrielle Haire [1]Bridget Gabriella Haire [1]
  1.  16
    Raising Rates of Childhood Vaccination: The Trade-Off Between Coercion and Trust.Bridget Haire, Paul Komesaroff, Rose Leontini & C. Raina MacIntyre - 2018 - Journal of Bioethical Inquiry 15 (2):199-209.
    Vaccination is a highly effective public health strategy that provides protection to both individuals and communities from a range of infectious diseases. Governments monitor vaccination rates carefully, as widespread use of a vaccine within a population is required to extend protection to the general population through “herd immunity,” which is important for protecting infants who are not yet fully vaccinated and others who are unable to undergo vaccination for medical or other reasons. Australia is unique in employing financial incentives to (...)
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   3 citations  
  2.  18
    How Good Is “Good Enough”? The Case for Varying Standards of Evidence According to Need for New Interventions in HIV Prevention.Bridget Haire, John Kaldor & Christopher Fc Jordens - 2012 - American Journal of Bioethics 12 (6):21-30.
    In 2010, randomized controlled trials (RCTs) of two different biomedical strategies to prevent HIV infection had positive findings. However, despite ongoing very high levels of HIV infection in some countries and population groups, it has been made clear by regulatory authorities that the evidence remains insufficient to support either product being made available outside of research contexts in the developing world for at least two years. In addition, prevention trials in endemic areas will continue to test new interventions against placebo. (...)
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   11 citations  
  3.  18
    Mind the Gap: An Empirical Study of Post‐Trial Access in HIV Biomedical Prevention Trials.Bridget Haire & Christopher Jordens - 2015 - Developing World Bioethics 15 (2):85-97.
    The principle of providing post-trial access for research participants to successful products of that research is widely accepted and has been enshrined in various declarations and guidelines. While recent ethical guidelines recognise that the responsibility to provide post-trial access extends to sponsors, regulators and government bodies as well as to researchers, it is the researchers who have the direct duty of care to participants. Researchers may thus need to act as advocates for trial participants, especially where government bodies, sponsors, and (...)
    Direct download (5 more)  
     
    Export citation  
     
    Bookmark   5 citations  
  4.  16
    Communities Need to Be Equal Partners in Determining Whether Research is Acceptable.Bridget G. Haire & John M. Kaldor - 2018 - Journal of Medical Ethics 44 (3):159-160.
    In many countries around the world, people who inject drugs remain at high risk of HIV acquisition not because effective forms of prevention are unknown, nor because they find effective prevention undesirable, but because those in charge, mainly politicians but also bureaucrats, find evidence-based practice politically unacceptable. The evidence for preventive efficacy of harm reduction strategies, most prominently needle and syringe programmes but also treatment programmes such as opiate substitution, is irrefutable.1 However, political responses to drug use issues are varied (...)
    Direct download (5 more)  
     
    Export citation  
     
    Bookmark   2 citations  
  5.  11
    Beyond Compliance Checking: A Situated Approach to Visual Research Ethics.Caroline Lenette, Jessica R. Botfield, Katherine Boydell, Bridget Haire, Christy E. Newman & Anthony B. Zwi - 2018 - Journal of Bioethical Inquiry 15 (2):293-303.
    Visual research methods like photography and digital storytelling are increasingly used in health and social sciences research as participatory approaches that benefit participants, researchers, and audiences. Visual methods involve a number of additional ethical considerations such as using identifiable content and ownership of creative outputs. As such, ethics committees should use different assessment frameworks to consider research protocols with visual methods. Here, we outline the limitations of ethics committees in assessing projects with a visual focus and highlight the sparse knowledge (...)
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   2 citations  
  6.  28
    Ethics of ARV Based Prevention: Treatment‐as‐Prevention and PrEP.Bridget Haire & John M. Kaldor - 2013 - Developing World Bioethics 13 (2):63-69.
    Published data show that new HIV prevention strategies including treatment-as-prevention and pre-exposure prophylaxis (PrEP) using oral antiretroviral drugs (ARVs) are highly, but not completely, effective if regimens are taken as directed. Consequently, their implementation may challenge norms around HIV prevention. Specific concerns include the potential for ARV-based prevention to reframe responsibility, erode beneficial sexual norms and waste resources. This paper explores what rights claims uninfected people can make for access to ARVs for prevention, and whether moral claims justify the provision (...)
    Direct download (6 more)  
     
    Export citation  
     
    Bookmark   5 citations  
  7.  56
    Ethical Considerations in Determining Standard of Prevention Packages for HIV Prevention Trials: Examining PrEP.Bridget Haire, Morenike Oluwatoyin Folayan, Catherine Hankins, Jeremy Sugarman, Sheena McCormack, Gita Ramjee & Mitchell Warren - 2013 - Developing World Bioethics 13 (2):87-94.
    The successful demonstration that antiretroviral (ARV) drugs can be used in diverse ways to reduce HIV acquisition or transmission risks – either taken as pre-exposure prophylaxis (PrEP) by those who are uninfected or as early treatment for prevention (T4P) by those living with HIV – expands the armamentarium of existing HIV prevention tools. These findings have implications for the design of future HIV prevention research trials. With the advent of multiple effective HIV prevention tools, discussions about the ethics and the (...)
    Direct download (9 more)  
     
    Export citation  
     
    Bookmark   4 citations  
  8.  16
    Ebola Vaccine Development Plan: Ethics, Concerns and Proposed Measures.Morenike Oluwatoyin Folayan, Aminu Yakubu, Bridget Haire & Kristin Peterson - 2016 - BMC Medical Ethics 17 (1):1-8.
    BackgroundThe global interest in developing therapies for Ebola infection management and its prevention is laudable. However the plan to conduct an emergency immunization program specifically for healthcare workers using experimental vaccines raises some ethical concerns. This paper shares perspectives on these concerns and suggests how some of them may best be addressed.DiscussionThe recruitment of healthcare workers for Ebola vaccine research has challenges. It could result in coercion of initially dissenting healthcare workers to assist in the management of EVD infected persons (...)
    Direct download (7 more)  
     
    Export citation  
     
    Bookmark   3 citations  
  9.  4
    Benefit of HIV Molecular Surveillance is Unclear, but Risks to Prevention Norms Are Clear.Bridget Haire - 2020 - American Journal of Bioethics 20 (10):47-49.
    Volume 20, Issue 10, October 2020, Page 47-49.
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   1 citation  
  10.  8
    Treatment-as-Prevention Needs to Be Considered in the Just Allocation of HIV Drugs.Bridget Haire - 2011 - American Journal of Bioethics 11 (12):48-50.
    The American Journal of Bioethics, Volume 11, Issue 12, Page 48-50, December 2011.
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark   5 citations  
  11.  12
    Ethics of Medical Care and Clinical Research: A Qualitative Study of Principal Investigators in Biomedical HIV Prevention Research.Bridget G. Haire - 2013 - Journal of Medical Ethics 39 (4):231-235.
    In clinical research there is a tension between the role of a doctor, who must serve the best interests of the patient, and the role of the researcher, who must produce knowledge that may not have any immediate benefits for the research participant. This tension is exacerbated in HIV research in low and middle income countries, which frequently uncovers comorbidities other than the condition under study. Some bioethicists argue that as the goals of medicine and those of research are distinct, (...)
    Direct download (6 more)  
     
    Export citation  
     
    Bookmark   3 citations  
  12.  5
    Beyond Compliance Checking: A Situated Approach to Visual Research Ethics.Anthony Zwi, Christy Newman, Bridget Haire, Katherine Boydell, Jessica Botfield & Caroline Lenette - 2018 - Journal of Bioethical Inquiry 15 (2):293-303.
    Visual research methods like photography and digital storytelling are increasingly used in health and social sciences research as participatory approaches that benefit participants, researchers, and audiences. Visual methods involve a number of additional ethical considerations such as using identifiable content and ownership of creative outputs. As such, ethics committees should use different assessment frameworks to consider research protocols with visual methods. Here, we outline the limitations of ethics committees in assessing projects with a visual focus and highlight the sparse knowledge (...)
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   1 citation  
  13.  28
    Because We Can: Clashes of Perspective Over Researcher Obligation in the Failed Prep Trials.Bridget G. Haire - 2011 - Developing World Bioethics 11 (2):63-74.
    This article examines the relationship between bioethics and the therapeutic standards in HIV prevention research in the developing world, focusing on the closure of the pre-exposure prophylaxis (PrEP) trials in the early 2000s. I situate the PrEP trials in the historical context of the vertical transmission debates of the 1990s, where there was protracted debate over the use of placebos despite the existence of a proven intervention. I then discuss the dramatic improvement in the clinical management of HIV and the (...)
    Direct download (5 more)  
     
    Export citation  
     
    Bookmark   3 citations  
  14.  83
    It’s Time: The Case for PrEP as an Active Comparator in HIV Biomedical Prevention Trials.Bridget Haire - 2015 - Journal of Bioethical Inquiry 12 (2):239-249.
    In July 2012, based on evidence from two major trials, the United States Food and Drug Administration approved the use of combined oral tenofovir/emtricitabine as pre-exposure prophylaxis for people at high risk of HIV acquisition. PrEP effectiveness is marred by poor adherence, however, even in trial populations, thus it is not a magic bullet for HIV prevention. It is, however, the most effective biomedical HIV prevention intervention available for people at high risk of HIV, particularly those who have receptive sex (...)
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   1 citation  
  15.  14
    “Reasonable Availability” Criterion Remains Salient.Bridget Gabrielle Haire - 2016 - American Journal of Bioethics 16 (6):19-21.
  16.  12
    Ebola: What It Teaches Us About Medical Ethics. A Response to Angus Dawson.Bridget G. Haire & Morenike O. Folayan - 2016 - Journal of Medical Ethics 42 (1):59-60.
    Direct download (4 more)  
     
    Export citation  
     
    Bookmark   1 citation  
  17.  20
    Debating Ethics in HIV Research: Gaps Between Policy and Practice in Nigeria.Morenike Oluwatoyin Folayan, Kristin Peterson, Bridget Haire, Brandon Brown, Kadiri Audu, Olumide Makanjuola, Babatunde Pelemo & Vicki Marsh - 2015 - Developing World Bioethics 15 (3):214-225.
    HIV prevention is a critical health issue in Nigeria; a country that has one of the worst HIV epidemic profiles in the world. With 270,000 new infections in 2012, Nigeria is a prime site for HIV prevention research. One effect of the HIV epidemic has been to revolutionalise ethical norms for the conduct of research: it is now considered unethical to design and implement HIV related studies without community engagement. Unfortunately, there is very little commensurate effort in building the capacity (...)
    Direct download (4 more)  
     
    Export citation  
     
    Bookmark   1 citation  
  18.  4
    HIV Transmission Law in the Age of Treatment-as-Prevention.Bridget Haire & John Kaldor - 2015 - Journal of Medical Ethics 41 (12):982-986.
  19.  3
    Prioritization of Healthcare Workers for Experimental Ebola Therapeutic Would Exacerbate Existing Inequalities.Morenike Oluwatoyin Folayan & Bridget Haire - 2015 - Developing World Bioethics 15 (2):113-114.
    Direct download (4 more)  
     
    Export citation  
     
    Bookmark   1 citation  
  20.  15
    No Sex Please in Sexuality Research.Bridget Haire - 2010 - American Journal of Bioethics 10 (7):43-44.
  21.  17
    Back to Basics in Clinical Research Ethics.Bridget Haire - 2009 - American Journal of Bioethics 9 (3):48 – 49.
  22.  13
    Considerations for Community Engagement When Conducting Clinical Trials During Infectious Disease Emergencies in West Africa.Morenike Oluwatoyin Folayan, Dan Allman, Bridget Haire, Aminu Yakubu, Muhammed O. Afolabi & Joseph Cooper - 2019 - Developing World Bioethics 19 (2):96-105.
  23.  4
    Considerations for Stakeholder Engagement and COVID‐19 Related Clinical Trials’ Conduct in Sub‐Saharan Africa.Morenike Oluwatoyin Folayan, Brandon Brown, Bridget Haire, Chinedum Peace Babalola & Nicaise Ndembi - 2021 - Developing World Bioethics 21 (1):44-50.
    Direct download (5 more)  
     
    Export citation  
     
    Bookmark  
  24.  17
    Screening Children for Caries: An Ethical Dilemma in Nigeria.Morenike Oluwatoyin Folayan, Bridget Gabriella Haire, Abiola A. Adeniyi & Wasiu Lanre Adeyemo - 2018 - The New Bioethics 24 (2):135-149.
    Dental caries is the main oral health challenge for children in Nigeria. Concern about its negative impact makes screening for caries in children an attractive public health strategy. The ability to detect the preclinical phase of caries, the availability of screening tools with high accuracy, and the possibility of treatment before onset of clinical symptoms with significant cost and health benefits, makes it appropriate for screening. However in Nigeria, the poor availability of highly specific and sensitive screening tools, poor access (...)
    No categories
    Direct download (4 more)  
     
    Export citation  
     
    Bookmark  
  25.  5
    Aspects of Disaster Research Ethics Applicable to Other Contexts.Bridget Haire - 2018 - Journal of Medical Ethics 44 (1):9-10.
    In his article ‘The Ebola Clinical Trials: a precedent for research ethics in disasters’, Philippe Calain constructs a compelling case as to why and how experiences from the recent Ebola epidemic should be used to develop a framework for disaster research ethics. In particular, Calain proposes a useful model for assessing whether or not an unproven intervention could be suitable for human use in a disaster context, and makes a powerful argument against the separation of patient care from research goals. (...)
    Direct download (5 more)  
     
    Export citation  
     
    Bookmark  
  26.  12
    Undue Inducement, or Unfair Exclusion: Considering a Case Study of Pregnancy in an HIV Prevention Trial.Bridget G. Haire & Morenike Oluwatoyin Folayan - 2017 - Journal of Medical Ethics 43 (12):829-830.
    In their recent paper‘Undue inducement: a case study in CAPRISA 008’, Mngadi et al conclude that a participant in an HIV prevention study who deliberately concealed her pregnancy was not ‘unduly induced’ to participate by the offer of an experimental product. This paper argues that while the authors’ conclusion is sound, the framing of this case study is consistent with the preoccupation in research ethics with the concept of undue inducement, coupled with a highly risk-averse attitude to pregnancy. We suggest (...)
    Direct download (5 more)  
     
    Export citation  
     
    Bookmark  
  27.  20
    Ethical Issues in Adolescents' Sexual and Reproductive Health Research in Nigeria.Morenike Oluwatoyin Folayan, Bridget Haire, Abigail Harrison, Morolake Odetoyingbo, Olawunmi Fatusi & Brandon Brown - 2015 - Developing World Bioethics 15 (3):191-198.
    There is increasing interest in the need to address the ethical dilemmas related to the engagement of adolescents in sexual and reproductive health research. Research projects, including those that address issues related to STIs and HIV, adverse pregnancy outcomes, violence, and mental health, must be designed and implemented to address the needs of adolescents. Decisions on when an individual has adequate capacity to give consent for research most commonly use age as a surrogate rather than directly assessing capacity to understand (...)
    Direct download (6 more)  
     
    Export citation  
     
    Bookmark